Valuation as at 2026-08-04 · refreshed with the ASX 300 Most Undervalued screen
About Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services.
Source: Yahoo Finance company profile · factual description, not KashVector commentary
Sonic Healthcare Limited SHL.AX
Healthcare · Diagnostics & Research
SHL.AX's price & financial trends
Annual reporting periods — this market does not have reliable quarterly data on Yahoo (either it isn’t required, or coverage is incomplete), so annual is the most granular consistent series across free cash flow and dividends.
Data refreshed 2026-08-04
Share price · last 2 years
Earnings per share (diluted)
Free cash flow
Dividend per share
Intrinsic value estimate · 5-year forecast
Assumptions used in this valuation
Every input below is either fetched live from Yahoo Finance or a documented default — nothing is hidden.
| Bear | Base | Bull | |
|---|---|---|---|
| 5-yr FCF growth | 6.1% | 12.3% | 18.4% |
| Terminal growth | 2.5% | 2.5% | 2.5% |
| WACC (discount rate) | 7.72% | 6.72% | 5.72% |
Cost of Equity = Risk-free rate + Beta × Equity Risk Premium = 4.80% + 0.59 × 6.00% = 8.33% · WACC = weighted by 65%/35% capital structure
These numbers come from running Sonic Healthcare Limited's cash flows through the mechanical DCF formula and assumptions above — not from any view on the news, management, or SHL.AX's competitive position. What is DCF?
Want to test your own growth or discount-rate assumptions?Open the full interactive calculator, pre-filled with SHL.AX →
More ASX 300 Most Undervalued stocks
Not financial advice. DCF valuations are highly sensitive to assumptions — small changes in growth rate or discount rate produce large swings in output. This is a mechanical calculation, not a recommendation to buy, hold, or sell.
About this valuation
Refreshed on the same cycle as the ASX 300 Most Undervalued screen. Change any assumption yourself in the full interactive tool.
Frequently asked questions
Is SHL.AX undervalued?
The Base-case DCF estimates intrinsic value at $34.00 vs a current price of $22.09 — a +53.9% margin, so the Base case reads undervalued. This is a mechanical output, not advice.